Type of Deal |
Value |
Acquirer |
Target |
Adviser to acquirer (tax) |
Adviser to target (tax) |
Acquisition |
$13.4 billion |
China Telecom Corporation |
CDMA network assets |
Sullivan & Cromwell / Jingtian & Gongcheng / Freshfields Bruckhaus Deringer |
|
Acquisition |
$3.7 billion |
Daikin Industries |
Goodman Global |
Davis Polk & Wardwell - Avishai Shachar |
Simpson Thacher & Bartlett |
Acquisition |
$3.7 billion |
M&T |
Hudson City |
Wachtell, Lipton, Rosen & Katz |
Sullivan & Cromwell |
Acquisition |
$3.1 billion |
Scotiabank |
ING Direct Canada |
Torys |
Sullivan & Cromwell - Ronald Creamer / Norton Rose |
Acquisition |
$430 million |
Sunovion Pharmaceuticals |
Elevation Pharmaceuticals |
Latham & Watkins - Laurence Stein |
|
Acquisition |
$253 million |
Western Mining Group |
Inter-Citic Minerals |
Stikeman Elliott |
Miller Thomson |
Business Transfer Agreement |
$200 million |
Hospira |
Orchid Pharma |
Khaitan & Co / Baker & McKenzie |
Latham & Watkins / Amarchand, Mangaldas & Co. |
Acquisition |
Undisclosed |
GENIVAR |
Smith Carter |
Stikeman Elliott |
|
Type of Deal |
Value |
Issuer/Borrower |
Lead managers/arrangers |
Adviser to issuer/borrower (tax) |
Adviser to lead managers (tax) |
Senior Notes Offering |
$1 billion |
LabCorp |
Credit Suisse / Merrill Lynch |
Hogan Lovells |
Davis Polk & Wardwell - Michael Farber |
PERLS VI Hybrid |
$770 million |
Commonwealth Bank of Australia |
Morgan Stanley / ANZ Securities / Goldman Sachs / Macquarie Capital / RBS / Westpac |
Freehills |
King & Wood Mallesons |
Deals of the week - September 3 2012
